CS
GMED icon

Cannell & Spears’s Globus Medical GMED Stock Holding History

Cannell & Spears’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,796
Closed -$446K – 422
2025
Q3 		$446K Sell
7,796
-2,775
-26% -$160K 0.01% 296
2025
Q2 		$624K Sell
10,571
-893
-8% -$57.7K 0.01% 261
2025
Q1 		$839K Sell
11,464
-2,615
-19% -$216K 0.02% 239
2024
Q4 		$1.16M Sell
14,079
-10,682
-43% -$842K 0.02% 230
2024
Q3 		$1.77M Sell
24,761
-4,357
-15% -$308K 0.03% 193
2024
Q2 		$1.99M Sell
29,118
-121,086
-81% -$7.23M 0.04% 171
2024
Q1 		$8.06M Buy
150,204
+42,542
+40% +$2.29M 0.17% 107
2023
Q4 		$5.74M Sell
107,662
-3,699
-3% -$180K 0.46% 33
2023
Q3 		$5.53M Buy
111,361
+21,903
+24% +$1.22M 0.47% 33
2023
Q2 		$5.33M Buy
89,458
+1,598
+2% +$91.1K 0.43% 36
2023
Q1 		$4.98M Buy
+87,860
New +$5.63M 0.45% 38
2021
Q4 		– Sell
-4,064
Closed -$311K – 237
2021
Q3 		$311K Hold
4,064
– – 0.02% 187
2021
Q2 		$315K Sell
4,064
-241
-6% -$17.1K 0.02% 189
2021
Q1 		$265K Sell
4,305
-950
-18% -$60.2K 0.02% 194
2020
Q4 		$343K Sell
5,255
-270
-5% -$15.5K 0.03% 166
2020
Q3 		$274K Sell
5,525
-58,560
-91% -$3.02M 0.03% 179
2020
Q2 		$3.06M Sell
64,085
-1,216
-2% -$58.7K 0.32% 48
2020
Q1 		$2.78M Buy
+65,301
New +$3.23M 0.34% 50

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cannell & Spears's GMED Position: Q4 2025 in Review

Cannell & Spears sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 7,796 shares — an estimated $446K sold.

Cannell & Spears first reported a position in GMED in Q1 2020 and held it in 18 quarters. The position peaked at $8.06M in Q1 2024. 561 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Cannell & Spears reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Cannell & Spears sold 7,796 Globus Medical shares in Q4 2025, an estimated $446K.
  • Cannell & Spears first reported a position in Globus Medical in Q1 2020 and held it in 18 quarters.
  • Cannell & Spears's Globus Medical position peaked at $8.06M in Q1 2024.
  • 561 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Cannell & Spears's 13F filing for Q4 2025, filed 17 Feb 2026.